Merck & Co. Inc. closed 33.72% short of its 52-week high of $134.63, which the company achieved on June 25th.
Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...
Zebra Technologies (ZBRA) and Merck KGaA (MKKGY) announced a new collaboration aimed at co-creating solutions to address challenges around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback